Form 4 for MLYS Mineralys Therapeutics, Inc.
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-09 · accession 0001628280-24-022631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-10 | 2024-05-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +100 | 67.1K | +0.1% | +$108 |
| D | 2024-05-10 | 2024-05-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -100 | 67.0K | -0.1% | -$1,500 |
| D | 2024-05-10 | 2024-05-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.00 | -100 | 203.1K | -0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-09 | M | A | 100 | $1.08 | 67,097 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-09 | S | D | 100 | $15.00 | 66,997 | D | — | — | |
| 3 | Derivative | Stock Option | 2024-05-09 | M | D | 100 | $0.00 | 203,054 | D | $1.08 · — to 2031-07-11 | 100 Common Stock | (F2) Due to a rounding error, the exercise price for this stock option was originally reported as $1.07 per share on the Reporting Person's Form 3 filed on February 9, 2023. (F3) The stock option vested with respect to 25% of the underlying shares on July 12, 2023, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter. |